Surgery Partners Q2 2022 Earnings Report
Key Takeaways
Surgery Partners, Inc. announced its second quarter 2022 results, with revenue increasing by 13.3% to $615.4 million and Adjusted EBITDA increasing by 13.4% to $86.1 million. The company performed over 149,000 surgical cases, a 7% increase from the prior year. They reaffirmed their 2022 Adjusted EBITDA guidance of $375 million to $385 million and revenue guidance of $2.5 billion to $2.6 billion.
Revenue increased 13.3% from the prior year period to $615.4 million.
Days adjusted same-facility revenues increased 6.9% from the prior year period.
Net loss attributable to common stockholders was $18.4 million.
Adjusted EBITDA increased 13.4% over the prior year period to $86.1 million, inclusive of a $0.1 million benefit from the recognition of CARES Act grants.
Surgery Partners
Surgery Partners
Surgery Partners Revenue by Segment
Forward Guidance
The Company continues to project 2022 Adjusted EBITDA in the range of $375 million to $385 million and 2022 revenue in the range of $2.5 billion to $2.6 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income